Navigation Links
Michael D. Farley Appointed Chief Operating Officer of Lupus Foundation of America, Inc.
Date:3/26/2008

WASHINGTON, March 26 /PRNewswire-USNewswire/ -- Michael D. Farley has joined the Lupus Foundation of America, Inc. national office in Washington, DC as the organization's Chief Operating Officer, where he will be responsible for the Foundation's overall organizational administration and field development. Farley has expertise in administering major national voluntary health organizations, including serving most recently as the interim CEO and Chief Community and Corporate Relations Officer for the American Diabetes Association. He also has served as Senior Vice President of Development with the USO World Headquarters, and Vice President for Field Development at the American Red Cross.

Farley will be responsible for the LFA's organization-wide operations and development, including research, public and professional education, internal and external communications, marketing, fund development, strategic partnerships, public policy, field operations, finance, and administration.

Founded more than 30 years ago, the LFA is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus and for providing support, services, and hope to all people affected by lupus. The LFA operates programs of research, education, and advocacy, and has a nationwide network of nearly 300 chapters, branches, and support groups.

In announcing Farley's appointment, LFA President and CEO Sandra C. Raymond cited Farley's extensive expertise in nonprofit administration and field development. "Michael Farley has 25 years of leadership in senior management positions with major national nonprofit organizations," Raymond said. "His experience will be instrumental in helping the LFA meet its critical priorities which are focused on increasing public and private sector support for medical research and expanding support and services to individuals who are affected by lupus."

Farley said this truly is an exciting time to join the Foundation. "New research initiatives hold promise for extraordinary advances in diagnosing and treating lupus. New information is being discovered about the causes of lupus, directly affecting more than 1.5 million Americans. New therapies are ready to emerge that will help manage and control this life-diminishing and life-threatening disease," said Farley. "The LFA is preparing to take advantage of these wonderful advances, and I am honored to do my part in supporting our leadership, scientists, and patient advocates across the country."

Lupus results from an unbalanced immune system that can be destructive to any organ or tissue in the body. Lupus is unpredictable and potentially fatal, yet no satisfactory treatment exists. For more information about lupus and the LFA, go online to lupus.org or call toll free 1-888-38-LUPUS to obtain a free information packet.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
4. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
5. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
6. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
7. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
8. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
9. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
10. Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response
11. Siemens Medical Solutions Michael Long Recognized as one of Computerworlds 2008 Premier 100 IT Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: